Company: SMNR
Filing Date: 2025-08-22
Form Type: DEFA14A
Source: 0001213900-25-079507
Chunk: 28

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-22
Form: DEFA14A
Chunk 28
---
, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including foreign, federal and state securities laws and regulations including all applicable foreign, federal, state laws, rules and regulations) applicable to Denali or Merger Sub or by which any property or asset of Denali or Merger Sub is bound or affected; except, in the case of clauses (ii) and (iii) above, as would not have or reasonably be expected to result in an Denali Material Adverse Effect.

(e) Consents. Denali is not required to obtain any consent from, authorization or order of, or make any filing or registration with, any court, governmental agency or any regulatory or self-regulatory agency or any other Person in order for it to execute, deliver or perform any of its obligations under or contemplated by the Denali Transaction Documents, in each case, in accordance with the terms hereof or thereof. All consents, authorizations, orders, filings and registrations which Denali is required to obtain pursuant to the preceding sentence have been obtained or effected on or prior to the Closing Date (or in the case of filings detailed above, will be made timely after the Closing Date), and Denali does not have knowledge of any facts or circumstances which are likely to prevent Denali from effecting any of the registration, application or filings contemplated by the Denali Transaction Documents.

(f) No General Solicitation. Neither Denali nor any of its affiliates, nor any Person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the Common Shares.

(g) No Integrated Offering. Assuming the accuracy of the Buyers’ representations and warranties in Section 2 and Semnur’s representations and warranties in Section 3, neither Denali nor any of its affiliates, nor any Person acting on their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would require registration of the issuance of any of the Common Shares under the 1933 Act, whether through integration with prior offerings or otherwise, or cause this offering of the Common Shares to require approval of stockholders of Denali for purposes of the 1933 Act or any applicable stockholder approval provisions, including, without limitation, under the rules and regulations of any exchange or automated quotation system on which any of the securities of Denali are listed or designated for